BioCatch vs MarqVision

BioCatch has a disclosed valuation of $1B, while MarqVision's valuation is not publicly available, making a direct size comparison difficult. BioCatch employs 100-500 people.

BioCatch has raised more in total funding at $213M, compared to MarqVision's $20M — a gap of $193M.

BioCatch holds the higher Awaira Score at 80/100, compared to MarqVision's 40/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 40-point gap that reflects meaningful differences in scale or traction.

BioCatch was founded by Avi Turgeman in 2011. MarqVision was founded by Holmes H. Kim in 2020. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. MarqVision: MarqVision provides AI-powered brand protection software that monitors e-commerce marketplaces, social media platforms, and the open web for counterfeit products, trademark infringement, and unauthorised brand usage, using computer vision and NLP to identify infringing listings at scale and automate takedown notice submission to platform operators. The company serves brand owners in luxury goods, consumer electronics, and fashion that face significant revenue loss from counterfeit product sales on global e-commerce platforms.\n\nThe company raised approximately $20 million in venture funding from investors including Portage Ventures and PayPal Ventures. MarqVision reports monitoring billions of listings across major marketplaces including Amazon, Alibaba, and eBay on behalf of brand clients, achieving automated enforcement rates that exceed what traditional brand protection teams can achieve through manual monitoring. The platform integrates with marketplace reporting APIs to accelerate the time from infringing listing detection to successful takedown.\n\nMarqVision competes in the AI brand protection market against Red Points, Corsearch, and MarkMonitor, as well as the in-house brand protection teams of large consumer brands. The e-commerce counterfeit problem has expanded significantly with the growth of cross-border marketplace platforms that connect buyers in developed markets with manufacturers of infringing goods in low-cost production regions. AI automation of the detection and enforcement process is the primary value proposition, as the volume of potentially infringing listings across global platforms exceeds what human monitoring teams can practically review.

BioCatch was founded first in 2011, giving it 9 years of additional market experience. MarqVision was founded later in 2020. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.

BioCatch has approximately 100-500 employees, while MarqVision has approximately 1-50. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.

Yes, BioCatch and MarqVision are direct competitors — both operate in the AI Security space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.